trial
as of 2026-07-01Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders
NCTId NCT07043803
at a glance
— · Completed
Enrollment 53 (actual)
Sponsored by University of Pittsburgh Medical Center
Primary completion 2026-05-31
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
53 (actual)
Study type
Interventional
Allocation
Randomized
Model
Sequential
Masking
None
Start
2025-07-16
Primary completion
2026-05-31
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
University of Pittsburgh Medical CenterLead Sponsor
University of Pittsburgh Medical CenterCollaborator
Investigators
1
Professor of Psychiatry, MDPrincipal Investigator
Sites
4 total
Altoona, United StatesErie, United StatesMcKeesport, United StatesPittsburgh, United States
Facts & assertions
4 sourced
Enrollment
53
Phase
NA
Primary Completion Date
2026-05-31
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
collaborator
indication
investigator